Awaiting the next quantum leap in diagnostic sensitivity
This article was originally published in Clinica
Executive Summary
Diagnostics companies are increasingly going down the R&D path to develop more sensitivity and better quantitation. Brian Kelly attempted to get to grips with this complex subject when he attended a high-tech scientific conference held in Cardiff last month.